Press release
The Impact Of Rising Infectious Disease Incidence On The Metagenomics Market: Strategic Insights Driving Metagenomics Market Momentum in 2025
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.How Large Will the Metagenomics Market Size By 2025?
Metagenomics experienced substantial expansion in the recent past and is projected to ascend from a valuation of $2.01 billion in 2024 to $2.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.0%; this upward trajectory during the historical span owes its momentum to progress in microbiome investigations, research linking ailments to specific associations, requirements for ecological surveillance, utility within agriculture and food sectors, and advancements in industrial biotechnology procedures.
How Big Is the Metagenomics Market Size Expected to Grow by 2029?
Anticipation is building for substantial expansion within the metagenomics market over the approaching years; projections indicate it will reach a valuation of $3.99 billion by 2029, propelled by a compound annual growth rate (CAGR) of 14.6%. This accelerated expansion throughout the forecast duration stems from several key factors, notably the incorporation of precision medicine approaches, deeper comprehension of microbial ecology, the establishment of one health programs, increased bioprospecting and drug development efforts, and advancements in diagnostic and therapeutic solutions. Furthermore, several significant trends are poised to shape the market landscape during this period, such as ongoing technological leaps in sequencing methodologies, the merging of artificial intelligence and machine learning capabilities, the advancement of single-cell metagenomics techniques, efforts to standardize metagenomic data, and rising consumer interest in personal wellness and tailored nutrition plans.
View the full report here:
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report
Which Key Market Drivers Powering Metagenomics Market Expansion and Growth?
Growing occurrences of communicable ailments are substantially fueling the expansion of the metagenomics sector. These transmissible ailments, stemming from the invasion of pathogenic microorganisms like bacteria, viruses, fungi, or parasites, spread between individuals or via alternative vectors. Metagenomics facilitates the examination of these infectious diseases by delving into the genetic makeup of the associated microbial populations, offering a complete view of their makeup, genetic variation, and potential interplay. To illustrate this impact, data released in February 2024 by the UK Health Security Agency indicated that tuberculosis instances in England saw a 10.7% surge throughout 2023, reaching 4,850 reported cases, up from 4,380 the preceding year. Consequently, this heightened spread of infectious diseases acts as a key catalyst for the market's progression in metagenomics.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10815&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Metagenomics Market?
The primary momentum driving the metagenomics sector currently stems from rapid technological development. Leading entities within this field are concentrating their efforts on integrating novel sequencing methodologies to bolster their analytical capabilities and maintain competitive standing. As a concrete illustration, May 2023 saw CD Genomics, a bioinformatics firm situated in the United States, introduce its Long-Read Metagenomic Sequencing offering. This sophisticated platform empowers investigators and scientific personnel to delve into the intricacies of microbial populations with superior precision and granularity. By leveraging CD Genomics' pioneering technology and deep expertise in genomics, patrons are positioned to enter an advanced phase of metagenomic inquiry. The service is characterized by superior clarity in data, precise species determination, detailed functional mapping, and robust comparative assessments. This progressive approach is anticipated to revolutionize the study of metagenomics by unlocking previously inaccessible understandings of microbial ecosystems.
What Are the Emerging Segments in the Metagenomics Market?
The metagenomicsmarket covered in this report is segmented -
1) By Product: Instruments; Kits And Reagents; Software And Services
2) By Workflow: Sequencing; Pre-Sequencing; Data Analysis
3) By Application: Environmental; Clinical Diagnostics; Drug Discovery; Biotechnology; Food And Nutrition; Other Applications
4) By End User: Pharmaceutical Industries; Research Laboratories; Biotechnology Companies; Pathology Laboratories; Academic And Research Institutes
Subsegments:
1) By Instruments: DNA Sequencers; PCR Machines; Microarray Systems; Mass Spectrometers
2) By Kits And Reagents: DNA Extraction Kits; Library Preparation Kits; Amplification Kits; Sequencing Reagents
3) By Software And Services: Data Analysis Software; Bioinformatics Services; Cloud-Based Data Storage; Consultation Services
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10815&type=smp
Who Are the Global Leaders in the Metagenomics Market?
Major companies operating in the metagenomics market include Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation
Which are the Top Profitable Regional Markets for the Metagenomics Industry?
North America was the largest region in the global metagenomics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10815
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Impact Of Rising Infectious Disease Incidence On The Metagenomics Market: Strategic Insights Driving Metagenomics Market Momentum in 2025 here
News-ID: 4272442 • Views: …
More Releases from The Business Research Company
Top Market Shifts Transforming the Pharma ADMET Testing Market Landscape: Key In …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Pharma ADMET Testing Market Through 2025?
The pharmaceutical admet testing market has recently experienced substantial expansion, projected to increase from a valuation of $9.67 billion in 2024 to $10.7 billion by 2025, reflecting a compound annual growth rate (CAGR) of 10.6%. This…
Mass Spectrometry Market Landscape to 2034: Key Forces Shaping the Next Decade o …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Mass Spectrometry Market Size By 2025?
The overall valuation of the mass spectrometry sector has experienced significant expansion recently, projected to increase from $6.65 billion in 2024 to reach $7.2 billion by the following year, reflecting an 8.3% compound annual growth rate during this timeframe;…
Rise In Road Accidents Drives Patient Transport Services Market: Powering Innova …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Patient Transport Services Market Through 2025?
The overall size of the patient transport services industry has witnessed robust expansion lately, projected to escalate from $40.33 billion in 2024 to $44.16 billion come 2025, reflecting a compound annual growth rate (CAGR) of 9.5%.Contributing…
Global Liquid Biopsy For Cancer Diagnostics Market Expected to Achieve 15.6% CAG …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Liquid Biopsy For Cancer Diagnostics Market Size By 2025?
The overall valuation of the liquid biopsy sector for cancer diagnosis has experienced swift expansion lately, climbing from 9.23$ billion in the year 2024 to reach 10.76$ billion come 2025, reflecting a compound annual growth rate…
More Releases for Metagenomi
2025-2034 Base-Editing Tools Market Evolution: Disruptions, Innovations, and Unt …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Base-Editing Tools Market Through 2025?
In recent times, the market size for base-editing tools has seen a staggering growth. Expected to expand from $1.50 billion in 2024 to $1.83 billion in 2025, it's forecasted to boast a compound annual growth rate (CAGR)…
Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) should contact t …
An investigation on behalf of current long-term investors in shares of Metagenomi, Inc. (NASDAQ: MGX) concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc. was announced.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (N …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: MGX stocks follows a lawsuit filed against Metagenomi, Inc. over…
Trump's "Stargate AI" Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
In a world where healthcare innovation is accelerating, companies leveraging artificial intelligence are leading the charge in transforming patient care, diagnostics, and therapeutic solutions. Their advancements in smart disinfection, AI-designed therapies, precision gene editing, and cardiovascular diagnostics are not only reshaping their industries but also unlocking tremendous growth potential. Here's how these cutting-edge companies are redefining the future of healthcare.
CS Diagnostics Corp. (OTCQB: CSDX) Launches Next-Gen Disinfectant MEDUSA a cutting-edge…
Lawsuit filed for Investors who lost money with shares of Metagenomi, Inc. (NASD …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 25, 2024. NASDAQ: MGX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors who lost money with Metagenomi, Inc. (NASDAQ: MGX) i …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements made between February 9 and 13, 2024.
Investors who purchased a significant amount of shares of Metagenomi, Inc. (NASDAQ: MGX) between February 9 and 13, 2024, have certain options and for certain investors are short and strict deadlines running.…